Jul 9, 2026 10:27AM
Jul 2, 2026 11:53AM
Jul 1, 2026 04:39AM
Jul 1, 2026 04:39AM
Jun 30, 2026 04:11PM
Jun 30, 2026 10:48AM
Jun 30, 2026 06:58AM Guggenheim Reiterates Buy Rating on Abivax (ABVX), 'ABVX remains our Best Idea'
Jun 30, 2026 05:53AM
Jun 29, 2026 04:02PM
Jun 5, 2026 11:00AM
Jun 3, 2026 12:49PM
Jun 2, 2026 11:00AM
Jun 2, 2026 08:57AM
Jun 2, 2026 07:37AM Wedbush Upgrades Abivax (ABVX) to Neutral
Jun 2, 2026 04:04AM
Jun 2, 2026 01:03AM
Jun 1, 2026 04:37PM
Jun 1, 2026 04:03PM
May 26, 2026 04:40AM
Apr 13, 2026 05:52AM
Apr 1, 2026 04:06PM Abivax files annual reports with French and US regulators
Mar 24, 2026 10:45AM
Mar 24, 2026 09:01AM
Mar 24, 2026 04:09AM
Mar 22, 2026 10:00AM
Mar 17, 2026 07:54AM
Mar 16, 2026 12:58AM
Feb 24, 2026 06:49AM Wedbush Starts Abivax (ABVX) at Underperform
Feb 23, 2026 04:42AM
Jan 13, 2026 06:07AM
Jan 12, 2026 09:32AM
Jan 12, 2026 06:07AM
Jan 8, 2026 04:22AM
Jan 8, 2026 04:16AM
Jan 8, 2026 03:58AM Leerink Partners on Abivax (ABVX): 'Key Clinical & Regulatory Catalysts on Track'
Dec 22, 2025 05:33AM
Dec 17, 2025 04:05PM
Dec 16, 2025 04:08AM
Nov 24, 2025 07:34AM
Nov 4, 2025 04:56AM
Oct 13, 2025 05:29AM
Oct 10, 2025 06:08AM Abivax (ABVX) PT Raised to $150 at Guggenheim, named 'Best Idea'
Oct 7, 2025 04:06AM
Oct 6, 2025 04:55AM
Oct 6, 2025 04:03AM
Sep 25, 2025 05:03AM
Sep 23, 2025 04:19AM
Sep 23, 2025 04:18AM
Sep 15, 2025 12:52PM Guggenheim on Abivax (ABVX): 'We expect ABVX to get a late-breaker and/or a plenary session at the UEGW'
Jul 29, 2025 08:27AM

433,251 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All